Guideline Implementation Through an Alliance of KT Researchers and Education Providers
通过 KT 研究人员和教育机构联盟实施指南
基本信息
- 批准号:228418
- 负责人:
- 金额:$ 1.45万
- 依托单位:
- 依托单位国家:加拿大
- 项目类别:Miscellaneous Programs
- 财政年份:2011
- 资助国家:加拿大
- 起止时间:2011-02-01 至 2012-02-01
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Continuing Professional Development (CPD) offices in Faculties of Medicine and National Specialty Societies (NSSs), are leaders in provision of accredited learning activities for Canada's over 60,000 physicians. Through collaboration of these organization
医学院和国家专业协会(nss)的持续专业发展(CPD)办公室是为加拿大6万多名医生提供认可学习活动的领导者。通过这些组织的合作
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Lindsay Elizabeth A其他文献
Lindsay Elizabeth A的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
Evaluating equitable access to diabetic retinopathy screening using social value judgement informed distributional cost-effectiveness analyses (Oppression framework informed equity cost-effectiveness analysis of diabetic retinopathy screening)
使用社会价值判断知情的分配成本效益分析评估糖尿病视网膜病变筛查的公平性(压迫框架知情的糖尿病视网膜病变筛查公平成本效益分析)
- 批准号:
495212 - 财政年份:2023
- 资助金额:
$ 1.45万 - 项目类别:
Automated system to improve compliance to diabetic retinopathy screening
自动化系统可提高糖尿病视网膜病变筛查的依从性
- 批准号:
10697609 - 财政年份:2023
- 资助金额:
$ 1.45万 - 项目类别:
Preventing Vision Loss from Diabetic Retinopathy: Guiding Primary Care Diabetic Retinopathy Screening in Canada Through the Use of Provincial Healthcare Administrative Data
预防糖尿病视网膜病变导致的视力丧失:通过使用省级医疗保健管理数据指导加拿大初级保健糖尿病视网膜病变筛查
- 批准号:
454377 - 财政年份:2021
- 资助金额:
$ 1.45万 - 项目类别:
Operating Grants
Autonomous AI to mitigate disparities for diabetic retinopathy screening in youth during and after COVID-19
自主人工智能可减少 COVID-19 期间和之后青年糖尿病视网膜病变筛查的差异
- 批准号:
10689400 - 财政年份:2021
- 资助金额:
$ 1.45万 - 项目类别:
Autonomous AI to mitigate disparities for diabetic retinopathy screening in youth during and after COVID-19
自主人工智能可减少 COVID-19 期间和之后青年糖尿病视网膜病变筛查的差异
- 批准号:
10598686 - 财政年份:2021
- 资助金额:
$ 1.45万 - 项目类别:
Handheld retinal camera for AI-based diabetic retinopathy screening
用于基于人工智能的糖尿病视网膜病变筛查的手持式视网膜相机
- 批准号:
10324087 - 财政年份:2021
- 资助金额:
$ 1.45万 - 项目类别:
NOT-OD-23-070: Empowering Cloud Computing for Non-image-based Diabetic Retinopathy Screening by Designing an EHR-oriented Incremental Learning Framework
NOT-OD-23-070:通过设计面向 EHR 的增量学习框架,为非基于图像的糖尿病视网膜病变筛查提供云计算支持
- 批准号:
10827780 - 财政年份:2021
- 资助金额:
$ 1.45万 - 项目类别:
Autonomous AI to mitigate disparities for diabetic retinopathy screening in youth during and after COVID-19
自主人工智能可减少 COVID-19 期间和之后青年糖尿病视网膜病变筛查的差异
- 批准号:
10309013 - 财政年份:2021
- 资助金额:
$ 1.45万 - 项目类别:
Preventing Vision Loss from Diabetic Retinopathy: Guiding Primary Care Diabetic Retinopathy Screening in Canada Through the Use of Provincial Healthcare Administrative Data
预防糖尿病视网膜病变导致的视力丧失:通过使用省级医疗保健管理数据指导加拿大初级保健糖尿病视网膜病变筛查
- 批准号:
446658 - 财政年份:2020
- 资助金额:
$ 1.45万 - 项目类别:
Operating Grants
Preventing blindness by going to where you are: Culturally-competent tele-retina programs to support newcomers to attend diabetic retinopathy screening
到你所在的地方预防失明:具有文化背景的远程视网膜项目,支持新移民参加糖尿病视网膜病变筛查
- 批准号:
420665 - 财政年份:2020
- 资助金额:
$ 1.45万 - 项目类别:
Operating Grants